Respiratory News and Research

RSS

Nuvo Research announces topline results from WF10 Phase 2 trial for treatment of allergic rhinitis

Nuvo Research Inc., a life sciences company with growing revenues and a diverse portfolio of topical products, today announced the results of its investigational Phase 2 clinical trial of WF10 (Trial) for the treatment of allergic rhinitis.

21 Dec 2015

Flu vaccine: the facts. An interview with Dr Lisa Maragakis

There are different formulations of the flu vaccine but in general they all do the same thing, which is to stimulate our body's immune system to recognize and fight against the influenza virus.

21 Dec 2015

Australian researchers develop new technique to combat chronic bacterial infections in hospitals

One of the scourges of infections in hospitals – biofilms formed by bacteria that stick to each other on living tissue and medical instruments, making them harder to remove – can be tricked into dispersing with the targeted application of nanoparticles and heat, researchers have found.

21 Dec 2015

Luminex's NxTAG Respiratory Pathogen Panel obtains FDA clearance

Luminex Corporation today announced that it has received FDA clearance for its NxTAG Respiratory Pathogen Panel that detects 20 clinically relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae and Mycoplasma pneumonia.

20 Dec 2015

New vaccine shows promise against Middle East respiratory syndrome in dromedary camels

An international research project with the involvement of Universitat Autònoma de Barcelona and the Animal Health Research Centre (IRTA-CReSA), has designed a vaccine shown to be effective in protecting dromedaries against the coronavirus (CoV) that causes Middle East respiratory syndrome (MERS).

18 Dec 2015

Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited, its drug R&D subsidiary, has initiated SANET-ep, a Phase III sulfatinib (HMPL-012) registration trial in China in patients with extra-pancreatic neuroendocrine tumors ("NETs"), which are all non-pancreatic NETs, including, for example, NETs originating in the lymph, lung and across the gastrointestinal tract.

18 Dec 2015

Findings show promising evidence for creating broad-spectrum antiviral

UW researchers working in collaboration with Kineta Inc. and the University of Texas at Galveston have shown that making a drug-like molecule to turn on innate immunity can induce genes to control infection in several -known viruses.

18 Dec 2015

Case Western scientist to lead a pair of studies to develop more effective treatment for CF

A scientist at Case Western Reserve University Frances Payne Bolton School of Nursing will lead a pair of studies to develop more effective treatment for symptoms of cystic fibrosis (CF), a life-threatening genetic disease that causes persistent lung infections and progressively limits the ability to breathe.

18 Dec 2015

New study finds a reason for ethnic disparity in CF diagnoses

Cystic fibrosis (CF) occurs less frequently in nonwhites than in whites, and nonwhites tend to be diagnosed at a later age. This late diagnosis often comes only once they have become symptomatic, rather than through newborn screening programs or molecular diagnostic testing.

16 Dec 2015

WuXi forms strategic alliance with MedImmune to accelerate development of biologics portfolio in China

WuXi AppTec, a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that it has formed a strategic alliance with MedImmune, the global biologics research and development arm of AstraZeneca.

16 Dec 2015

Researchers discover new way for early detection of potentially deadly fungal infection in leukemia patients

A team of researchers have discovered a new way for early detection of a potentially deadly fungal infection in patients with suppressed immune systems such as those being treated for leukemia or have had an organ transplant.

15 Dec 2015

Nutritionist offers myriad methods to help people eat during cancer treatment

Ernestine Trujillo, MS, RD, LD, plays an important role in helping people through their cancer treatment: she helps them to eat. Eating keeps their strength up so that they can get through treatment. But eating during cancer treatment isn't always easy. Trujillo, a Senior Clinical Nutritionist at the University of New Mexico Comprehensive Cancer Center, offers myriad methods to help people get the nutrition they need.

13 Dec 2015

BD announces launch of BD FACSCelesta flow cytometer during ASCB annual meeting

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the BD FACSCelesta flow cytometer during the 2015 American Society for Cell Biology annual meeting. Uniquely designed to leverage the broad BD Horizon Brilliant reagent portfolio, this new system offers simultaneous measurement of up to 14 different single cell characteristics.

13 Dec 2015

U.S. has sufficient capacity for treating Ebola outbreak but financial, resource challenges remain as hurdle

The United States has sufficient capacity for treating another outbreak of the Ebola virus, but financial, staffing and resource challenges remain a hurdle for many hospitals and health systems attempting to maintain dedicated treatment centers for highly infectious diseases, according to new study released today.

12 Dec 2015

NIAID scientists successfully test prime-boost H7N9 influenza vaccine concept in clinical trial

In clinical trials, several candidate H7N9 pandemic influenza vaccines made from inactivated viruses have been shown to be safe and to generate an immune response. However, scientists believe for practical use, these potential vaccines would require multiple doses or the addition of adjuvants, which enhance the immune response.

12 Dec 2015

Halyard Health to develop high-speed machine to manufacture respirators for use during pandemic

Halyard Health Inc., formerly Kimberly-Clark Health Care, today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR). Under the contract, BARDA will fund research by Halyard to develop a one-of-a-kind, high-speed machine to manufacture N95 Filtering Facepiece Respirators (FFRs) that can be used during a pandemic.

10 Dec 2015

CareFusion obtains two FDA clearances for spine augmentation devices

CareFusion, a BD company, today announced the U.S. Food and Drug Administration has cleared two 510(k)s for its spine augmentation devices.

10 Dec 2015

Boehringer Ingelheim begins SENSCIS study to investigate safety, efficacy of nintedanib in patients with SSc-ILD

Boehringer Ingelheim announced today that the first person has been enrolled in the SENSCIS (Safety and Efficacy ofNintedanib in Systemic SClerosIS) study.

10 Dec 2015

Older men with sleep-disordered breathing at greater risk of developing atrial fibrillation

Sleep-disordered breathing often predicts the development of atrial fibrillation (AF) in older men, according to U.S. researchers.

9 Dec 2015

Adverse environmental changes present potential health hazards to eyes

Another reason to worry about climate change: Expanding areas of arid land, air pollution, and greater exposure to ultraviolet (UV) radiation all present potential health hazards to your eyes, according to Sheila West, Ph.D., vice chair for research at the Wilmer Eye Institute, Johns Hopkins University.

9 Dec 2015

Respiratory News and Research

Nuvo Research announces topline results from WF10 Phase 2 trial for treatment of allergic rhinitis

Flu vaccine: the facts. An interview with Dr Lisa Maragakis

Australian researchers develop new technique to combat chronic bacterial infections in hospitals

Luminex's NxTAG Respiratory Pathogen Panel obtains FDA clearance

New vaccine shows promise against Middle East respiratory syndrome in dromedary camels

Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China

Findings show promising evidence for creating broad-spectrum antiviral

Case Western scientist to lead a pair of studies to develop more effective treatment for CF

New study finds a reason for ethnic disparity in CF diagnoses

WuXi forms strategic alliance with MedImmune to accelerate development of biologics portfolio in China

Researchers discover new way for early detection of potentially deadly fungal infection in leukemia patients

Nutritionist offers myriad methods to help people eat during cancer treatment

BD announces launch of BD FACSCelesta flow cytometer during ASCB annual meeting

U.S. has sufficient capacity for treating Ebola outbreak but financial, resource challenges remain as hurdle

NIAID scientists successfully test prime-boost H7N9 influenza vaccine concept in clinical trial

Halyard Health to develop high-speed machine to manufacture respirators for use during pandemic

CareFusion obtains two FDA clearances for spine augmentation devices

Boehringer Ingelheim begins SENSCIS study to investigate safety, efficacy of nintedanib in patients with SSc-ILD

Older men with sleep-disordered breathing at greater risk of developing atrial fibrillation

Adverse environmental changes present potential health hazards to eyes

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News